Nodality utilizes proprietary single cell based technology to characterize signaling pathways in cancer and autoimmune diseases to better link individual patients with appropriate therapies through both the development and commercialization of highly predictive clinical tests, and to reduce time, cost, and risks of drug development.
|Clinical Research Associate||South San Francisco, CA, US|
|Director/Sr. Director of Business Development and Finance||South San Francisco, CA, US|
|RESEARCH ASSOCIATE – GLP/GMP LABORATORY||South San Francisco, CA, US|
|Scientist - Bioinformatics/Data Scientist||South San Francisco, CA, US|